Community-Based Access to Injectables | Subcutaneous DMPA (depo-subQ)

Around the world, use of injectable contraceptives is rising dramatically-- by 2015 the number of married women worldwide using injectables is projected to reach nearly 40 million. The increasing demand for injectables challenges programs to expand access to and improve the quality of services. Expanding access to injectable contraceptives with high-quality services helps fulfill women’s right to contraceptive choice and contributes to sustainable family planning programs.

• Accurate information
• Up-to-date policies and guidelines
• Quality training, supervision, and services
• Effective communication and marketing
• Proper logistics

Information, tools, and resources on these topics are listed under the main thematic navigation tabs above.

One way to increase use of injectable contraceptives is by expanding community-based access to injectables. Click on the Community-Based Access to Injectables link at the top of this page to learn more about this approach. You can also learn more about Subcutaneous DMPA (depo-subQ)—a new lower-dose formulation of DMPA that is injected under the skin rather than in the muscle.

If you have an experience or publication about the introduction or provision of injectables to share, we invite you to email us about it at toolkits@k4health.org or to post on the Discussion Board. To find out if a resource has already been included in this toolkit, visit the site map or type the title in the search box at the top of any toolkit page and click on the magnifying glass icon. Visit the About link at the top of this page for more detailed information about who selected the resources, a list of publishers, and other K4Health Toolkits.

Learn more about Hormonal Methods of Contraception. Take the Global Health eLearning course (registration required).